These 4 stocks could jump 100% in 30 days

If you knew a stock had an 83% chance of going up, would you consider buying it? You're receiving this email as part of your subscription to Crowdability. [Unsubscribe here](. [Crowdability] Dear Reader, If you knew a stock had an 83% chance of going up, would you consider buying it? I'd hope so. Of course, no one can predict those types of odds for certain... But thanks to a complete breakthrough in artificial intelligence, we're one step closer. [It's called Prometheus AI](. Prometheus was trained to do one specific thing: Detect stocks that jump 100% or more in four weeks or less... BEFORE it happens. Let me show you an example from a backtest... On May 23, Prometheus predicted a microcap stock called Altimmune had an 83% chance of experiencing a huge run-up in price. Almost immediately, the stock took off. And over the next couple months, Altimmune would surge 343%. This is just one of countless examples. Recently, the creator of Prometheus [sat down for an interview]( where he revealed exactly how Prometheus works... what it's predicting about some of the market's most talked-about stocks... and how to get your hands on four urgent buys that Prometheus believes could job 100% or more over the next 30 days. [The full replay is available right here](. Be sure to watch soon – these predictions could have serious ramifications for your portfolio. Regards, Sam Latter Editor in Chief, Crowdability Copyright © 2023 Crowdability, Inc., All rights reserved. You signed up on []( [Add us to your address book]( Our mailing address is: 1125 N. Charles Street Baltimore, Maryland 21201 [Update Subscription Preferences]( | [Unsubscribe from this list]( The work included in this communication is based on diverse sources including SEC filings, current events, interviews, corporate press releases, and information published on funding platforms, but the views we express and the conclusions we reach are our own. As such, this content may contain errors, and any investments described in this content should be made only after reviewing the filings and/or financial statements of the company, and only after consulting with your investment advisor. Actual results may differ significantly from the results described herein. Furthermore, nothing published by Crowdability, Inc should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized investment advice. Crowdability has no relationship with any of the companies or platforms we write about. Crowdability is an independent provider of education, information and research on start-ups and alternative investments, and as such, it accepts no compensation from any companies or funding platforms mentioned in any of our reports.